Susquehanna International Group
BRTX icon

Susquehanna International Group’s BioRestorative Therapies BRTX Stock Holding History

Susquehanna International Group’s Portfolio BRTX Stock Details BRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12,774
Closed -$22.2K – 12223
2024
Q3 		$22.2K Buy
+12,774
New +$21K ﹤0.01% 11608

Other funds holding BRTX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SG
StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.01B AUM 19.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UFA
US Financial Advisors Braintree, Massachusetts $338M AUM 4.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NDSI
Newman Dignan & Sheerar Inc Providence, Rhode Island $523M AUM 26.16% 1-Year Est. Return

Susquehanna International Group's BRTX Position: Q4 2024 in Review

Susquehanna International Group sold out of BioRestorative Therapies (BRTX) in Q4 2024, closing a stake of 12,774 shares — an estimated $22.2K sold.

Susquehanna International Group first reported a position in BRTX in Q3 2024 and held it in 1 quarter. The position peaked at $22.2K in Q3 2024. 15 funds tracked by Wall St. Rank hold BRTX as of Q4 2024.

  • Susquehanna International Group reported no remaining BioRestorative Therapies position as of Q4 2024 after selling out during the quarter.
  • Susquehanna International Group sold 12,774 BioRestorative Therapies shares in Q4 2024, an estimated $22.2K.
  • Susquehanna International Group first reported a position in BioRestorative Therapies in Q3 2024 and held it in 1 quarter.
  • Susquehanna International Group's BioRestorative Therapies position peaked at $22.2K in Q3 2024.
  • 15 funds tracked by Wall St. Rank held BioRestorative Therapies as of Q4 2024.

Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.